Mohand Ait Ahmed holds a master degree in Physiology (University Paris V – René Descartes) and a specialization in the fields of clinical research. He worked, first as Clinical Research Assistant (CRA) then as Clinical Project Manager (CPM). As part of his CRA and CPM’s activities for some academic institutions (AFM, AP-HP and ANRS) and for a CRO, he was involved in the monitoring and the quality assurance of several projects including clinical trials (phase II to IV) in different therapeutic areas: oncology, intensive care and infectious diseases. He joined Institut Pasteur in 2013 as Clinical Project Manager, first in the Emerging Disease Epidemiology unit for the coordination of several studies conducted in Egypt on Hepatitis C then in the Clinical Core of the CRT for the management of several projects. Since 2015, he is the quality deputy of CRT-CC. In this framework, he assists the unit in the CRT’quality process for obtaining the ISO 9001:2015 certification (CRT certification obtained in 2017).
A descriptive analysis of pertussis in 4 different regions of the world Coordinated by Fabien Taieb, physician affiliated with the Center for Translational Science at the Institut Pasteur, responsible for the coordination of the […]
MITICA: Identifying the mechanisms of acquisition of a dysbiotic microbiota and pediatric environmental enteropathy in infants in the context of chronic malnutrition
Undernutrition contributes to more than 40% of the global child mortality rate. In 2014 stunting, which is the main manifestation of chronic undernutrition, affected 159 million children. Stunting entails long-term repercussions for the child, […]
SaMARA: Surveillance and Monitoring of Antimalarial Resistance in Africa
Our knowledge on P. falciparum drug resistance has considerably progressed, particularly with the discovery of molecular markers associated to artemisinin derivatives and partner drugs (piperaquine, mefloquine) resistances. However, the race between effective antimalarial treatments […]
2015Hepatitis C virus seroprevalence in adults in Africa: a systematic review and meta-analysis, J. Viral Hepat. 2016 Apr;23(4):244-55.
2015Complications and competing risks of death in compensated viral cirrhosis (ANRS CO12 CirVir prospective cohort), Hepatology 2015 Sep;62(3):737-50.
2011Primary liver cancer is more aggressive in HIV-HCV coinfection than in HCV infection. A prospective study (ANRS CO13 Hepavih and CO12 Cirvir), Clin Res Hepatol Gastroenterol 2012 Jun;36(3):214-21.